Positron Emission Radiomics With PSMA Radioligands on Newly Diagnosed Prostate Cancer Patients

CompletedOBSERVATIONAL
Enrollment

70

Participants

Timeline

Start Date

April 15, 2023

Primary Completion Date

April 15, 2024

Study Completion Date

December 31, 2024

Conditions
Prostate Cancer
Interventions
OTHER

Immunohistochemistry (IHC) analysis

Setting of the percentage amount of PSMA expression on the primary tumor cell surface on post-surgical samples by the Immunohistochemistry method (IHC)

Trial Locations (1)

00168

GSTeP FPG Policlinico Gemelli IRCCS, Roma

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER